| For: | Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol 2015; 4(2): 169-184 [PMID: 25949931 DOI: 10.5527/wjn.v4.i2.169] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v4/i2/169.htm |
| Number | Citing Articles |
| 1 |
Maurizio Bruschi, Simona Granata, Giovanni Candiano, Antonia Fabris, Andrea Petretto, Gian Marco Ghiggeri, Giovanni Gambaro, Gianluigi Zaza. Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease. International Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215517
|
| 2 |
Wai Han Yiu, Rui Xi Li, Dickson W L Wong, Hao Jia Wu, Kam Wa Chan, Loretta Y Y Chan, Joseph C K Leung, Kar Neng Lai, Steven H Sacks, Wuding Zhou, Sydney C W Tang. Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy. Nephrology Dialysis Transplantation 2018; 33(8) doi: 10.1093/ndt/gfx336
|
| 3 |
Sandra Wymann, Yun Dai, Anup G. Nair, Helen Cao, Glenn A. Powers, Anna Schnell, Genevieve Martin-Roussety, David Leong, Jason Simmonds, Kim G. Lieu, Mitchell J. de Souza, Marcel Mischnik, Shirley Taylor, Saw Yen Ow, Martin Spycher, Rebecca E. Butcher, Martin Pearse, Adrian W. Zuercher, Adriana Baz Morelli, Con Panousis, Michael J. Wilson, Tony Rowe, Matthew P. Hardy. A novel soluble complement receptor 1 fragment with enhanced therapeutic potential. Journal of Biological Chemistry 2021; 296 doi: 10.1074/jbc.RA120.016127
|
| 4 |
Louise Oni. Paediatric immune-mediated renal disease: an overview. Nephrology Dialysis Transplantation 2021; 36(4) doi: 10.1093/ndt/gfz184
|
| 5 |
Wolfgang Winnicki, Peter Pichler, Karl Mechtler, Richard Imre, Ines Steinmacher, Gürkan Sengölge, Daniela Knafl, Georg Beilhack, Ludwig Wagner. A novel approach to immunoapheresis of C3a/C3 and proteomic identification of associates. PeerJ 2019; 7 doi: 10.7717/peerj.8218
|
| 6 |
Giuseppina Rosso, Maurizio Salvadori. Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN. World Journal of Nephrology 2016; 5(4): 308-320 doi: 10.5527/wjn.v5.i4.308
|
| 7 |
C Wehling, O Amon, M Bommer, B Hoppe, K Kentouche, G Schalk, R Weimer, M Wiesener, B Hohenstein, B Tönshoff, R Büscher, H Fehrenbach, Ö-N Gök, M Kirschfink. Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders. Clinical and Experimental Immunology 2017; 187(2) doi: 10.1111/cei.12890
|
| 8 |
Arun Chutani, Sayna Norouzi, Edgar V Lerma. C3 glomerulopathy in transplant “like yet unlike native”: Pathophysiology, recent advances in therapeutics and evolving paradigms. World Journal of Transplantation 2026; 16(2): 117138 doi: 10.5500/wjt.v16.i2.117138
|
| 9 |
Liangjing Lv, Yong Liu, Jiachuan Xiong, Shaobo Wang, Yan Li, Bo Zhang, Yinghui Huang, Jinghong Zhao. Role of G protein coupled receptors in acute kidney injury. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01802-8
|
| 10 |
Antonio Mastrangelo, Jessica Serafinelli, Marisa Giani, Giovanni Montini. Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00205
|
| 11 |
Margarita Semis, Gabriel B. Gugiu, Ellen A. Bernstein, Kenneth E. Bernstein, Markus Kalkum. The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma. Analytical Chemistry 2019; 91(10) doi: 10.1021/acs.analchem.8b03828
|
| 12 |
Sebastian Weiss, Alva Rosendahl, Daniel Czesla, Catherine Meyer-Schwesinger, Rolf A. K. Stahl, Heimo Ehmke, Christian Kurts, Peter F. Zipfel, Jörg Köhl, Ulrich O. Wenzel. The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension. American Journal of Physiology-Renal Physiology 2016; 310(11) doi: 10.1152/ajprenal.00040.2016
|
| 13 |
Morten Schøler Fast, Kathrin Weyer, Henrik Pedersen, Gregers Rom Andersen, Henrik Birn. Filtration and tubular handling of EWE‐hC3Nb1, a complement inhibitor nanobody, in wild type mice and a mouse model of proteinuric kidney disease. FEBS Open Bio 2024; 14(2) doi: 10.1002/2211-5463.13752
|
| 14 |
Burhan Yokus, Luca Maccioni, Lihong Fu, György Haskó, Laura E. Nagy, Bin Gao, Pal Pacher. The Link between Alcohol Consumption and Kidney Injury. The American Journal of Pathology 2026; 196(1) doi: 10.1016/j.ajpath.2025.05.011
|
| 15 |
David Cucchiari, Manuel Alfredo Podestà, Claudio Ponticelli. The Critical Role of Innate Immunity in Kidney Transplantation. Nephron 2016; 132(3) doi: 10.1159/000444267
|
| 16 |
Marion Anliker-Ort, Jasper Dingemanse, John van den Anker, Priska Kaufmann. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.599417
|
| 17 |
Tonmay Barai, Koushik Bhatttacharjee, Keya Basu, Sanjay Dasgupta. Primary immune complex membranoproliferative glomerulonephritis and C3 glomerulonephritis: experience of two rare diseases from a single centre. International Journal of Research in Medical Sciences 2025; 13(7) doi: 10.18203/2320-6012.ijrms20252031
|
| 18 |
Marlies Bode, Jan Niklas Diemer, The Vinh Luu, Nikolas Ehnert, Teresa Teigeler, Thorsten Wiech, Maja T. Lindenmeyer, Georg R. Herrnstadt, Jasmin Bülow, Tobias B. Huber, Nicola M. Tomas, Ulrich O. Wenzel. Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease. British Journal of Pharmacology 2023; 180(18) doi: 10.1111/bph.16097
|